These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23613832)

  • 1. Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complications.
    Pathania S; Randhawa V; Bagler G
    PLoS One; 2013; 8(4):e61327. PubMed ID: 23613832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SerpentinaDB: a database of plant-derived molecules of Rauvolfia serpentina.
    Pathania S; Ramakrishnan SM; Randhawa V; Bagler G
    BMC Complement Altern Med; 2015 Aug; 15():262. PubMed ID: 26238452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.
    Dubey K; Dubey R; Gupta R; Gupta A
    Curr Comput Aided Drug Des; 2021; 17(2):307-313. PubMed ID: 32208122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of rhodanine derivatives as aldose reductase inhibitors.
    Agrawal YP; Agrawal MY; Gupta AK
    Chem Biol Drug Des; 2015 Feb; 85(2):172-80. PubMed ID: 24903533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
    Ottanà R; Paoli P; Cappiello M; Nguyen TN; Adornato I; Del Corso A; Genovese M; Nesi I; Moschini R; Naß A; Wolber G; Maccari R
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study.
    Antony P; Vijayan R
    PLoS One; 2015; 10(9):e0138186. PubMed ID: 26384019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
    Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
    Maccari R; Ottanà R
    J Med Chem; 2015 Mar; 58(5):2047-67. PubMed ID: 25375908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.
    Prior AM; Thapa M; Hua DH
    Mini Rev Med Chem; 2012 Apr; 12(4):326-36. PubMed ID: 22303947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
    Giannoukakis N
    Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
    Kousaxidis A; Petrou A; Lavrentaki V; Fesatidou M; Nicolaou I; Geronikaki A
    Eur J Med Chem; 2020 Dec; 207():112742. PubMed ID: 32871344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
    Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
    Molecules; 2021 May; 26(10):. PubMed ID: 34066081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospecting and Structural Insight into the Binding of Novel Plant-Derived Molecules of Leea indica as Inhibitors of BACE1.
    Hosen SMZ; Rubayed M; Dash R; Junaid M; Mitra S; Alam MS; Dey R
    Curr Pharm Des; 2018; 24(33):3972-3979. PubMed ID: 30398111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
    Yabe-Nishimura C
    Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening of Korean forest plants for rat lens aldose reductase inhibition.
    Kim HY; Oh JH
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):184-8. PubMed ID: 10052140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
    Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
    J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico Designing of Novel Inhibitors for Triple Inhibition of Aldose Reductase, Aldose Reductase Like Protein 1, and Aldehyde Reductase.
    Devi A
    Curr Comput Aided Drug Des; 2020; 16(6):707-717. PubMed ID: 31749429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.